Memory CD8 T Cell Responses After Multiple Antigen Encounters
Memory CD8 T Cell Responses After Multiple Antigen Encounters
批准号:
7695307
负责人:
VLADIMIR P BADOVINAC
金额:
$37.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2013-06-30
关键词:
Adoptive TransferAntigensCD8B1 geneCell CountCellsCharacteristicsCommunicable DiseasesCoupledDataGenerationsGoalsHumanImmune responseImmunityImmunizationIndividualInfectionInflammationInflammatoryKnowledgeLongevityMemoryMethodologyModelingMusPhenotypePopulationPropertyProtocols documentationRecording of previous eventsRoleSecondary ImmunizationSignal TransductionT-LymphocyteTestingTimeVaccinationVaccinesbasecancer immunotherapyfunctional disabilityin vivomouse modelnovelpathogenpathogen exposurepublic health relevanceresponsevaccination strategy
中文摘要
描述(由申请人提供):在感染或免疫后产生和维持记忆性CD8 T细胞群的能力是适应性免疫反应的标志,也是预防传染病或癌症免疫治疗的保护性疫苗接种的基础。由于对感染的保护水平与病原体暴露时存在的记忆性CD8 T细胞的数量成正比,因此目前使用的许多疫苗都涉及初始免疫,然后是一次或多次加强免疫(“初始-加强”方案)。同样,仅接受一次免疫接种的个体在遇到病原体时可能会受到第二次刺激,即使没有接种疫苗,个体也可能暴露于同一病原体的多轮感染。因此,有必要了解多次抗原暴露后产生的CD8 T细胞反应。重要的是,大多数关于记忆性CD8 T细胞的研究都集中在对原发感染或疫苗接种的反应上。这是一个关键的知识缺口,因为不知道ag暴露的数量如何影响CD8 T细胞群的特征及其防御感染的能力。我们的长期目标是充分了解多种抗原接触对CD8 T细胞群的功能影响。这一信息对于了解如何最好地产生和操纵通过疫苗接种获得的保护性免疫具有重要意义。我们将检验抗原刺激的数量将决定记忆性CD8 T细胞群的重要表型和功能特征的中心假设。基于我们在小鼠感染模型和CD8 T细胞免疫方面的专业知识以及强有力的初步数据指导,我们已经做好了充分的准备来开展这些研究。我们已经开发了新的方法,可以全面和详细地分析CD8 T细胞群对多种抗原的反应。因此,我们提出以下具体目标:SA1 -确定抗原遭遇的数量如何控制CD8 T细胞的寿命。SA2 -评估记忆性CD8 T细胞群对多种抗原刺激的表型和功能差异。SA3 -确定炎症在继发性(20)和三级(30)记忆性CD8 T细胞反应产生中的作用。公共卫生相关性:大多数记忆性CD8 T细胞的研究都集中在对原发性(10)感染和/或疫苗接种的反应上。然而,加强免疫通常用于增加保护性CD8 T细胞数量,并且是用于保护人类免受传染病的疫苗的共同特征。该建议的目标是充分表征多轮ag刺激对CD8 T细胞群施加的功能后果,这将对理解如何最好地通过疫苗接种产生保护性免疫具有重要意义。
英文摘要
DESCRIPTION (provided by applicant): The ability to develop and sustain populations of memory CD8 T cells after infection or immunization is a hallmark of the adaptive immune response and one basis for protective vaccination against infectious disease or in cancer immunotherapy. Since the level of protection to infection is proportional to the number of memory CD8 T cells present at the time of pathogen exposure, many vaccines in use today involve an initial immunization that is followed by one or more booster ('prime-boost' protocols) immunizations. Similarly, individuals that receive only a single immunization may receive a secondary stimulation when they encounter the pathogen and, even in the absence of vaccination individuals might be exposed to multiple rounds of infection with the same pathogen. Therefore, there is a need to understand CD8 T cell responses generated after numerous antigen exposures. Importantly, most studies of memory CD8 T cells have focused on the response to primary (1o) infection or vaccination. This is a critical knowledge gap since it is not known how the number of Ag-exposures can influence the characteristics of CD8 T cell populations and their ability to defend against infection. Our long term goal is to fully understand the functional consequences imposed on CD8 T cell populations by multiple antigen encounters. This information will be significant in understanding how best to generate and manipulate protective immunity achieved by vaccination. We will test the central hypothesis that the number of antigen-stimulations will dictate the important phenotypic and functional characteristics of memory CD8 T cell populations. We are well prepared to undertake these studies based upon our expertise in mouse models of infections and CD8 T cell immunity coupled with the guidance of strong preliminary data. We have developed novel methodologies that will enable comprehensive and detailed analyses of CD8 T cell populations responding to multiple antigen encounters. Thus, we propose the following Specific Aims: SA1 - Determine how the number of antigen encounters controls the longevity of CD8 T cells. SA2 - Evaluate the phenotypic and functional differences between memory CD8 T cell populations in response to multiple antigen-stimulations. SA3 - Define the role of inflammation in generation of secondary (2o) and tertiary (3o) memory CD8 T cell responses. Public Health Relevance: Most studies of memory CD8 T cells have focused on the response to primary (1o) infection and/or vaccination. However, booster immunizations are often used to increase protective CD8 T cell numbers and are common feature of vaccines used to protect humans against infectious disease. The goal of this proposal, to fully characterize the functional consequences imposed on CD8 T cell populations by multiple rounds of Ag-stimulations, will be significant in understanding how best to generate protective immunity by vaccination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state
-
批准号:10557190
-
项目类别:
-
资助金额:$38.52万
-
财政年份:2020
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Evaluation of CC mice as an improved model for influenza immunity
-
批准号:10117187
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2020
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Differentiation of pathogen-specific memory CD8 T cell responses
-
批准号:9814211
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2019
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Molecular mechanisms controlling differentiation of memory CD8 T cells
-
批准号:8949463
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Impairment and recovery of CD8 T cell responses after sepsis
-
批准号:9128672
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Impairment and recovery of CD8 T cell responses after sepsis
-
批准号:9302800
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:9884079
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10534144
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10317045
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10077814
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:8960855
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8250161
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8416310
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8094471
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:7877845
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8286365
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: